John's wort use in HIV are limited by the prevalence of interactions between St. John's wort and standard HIV therapy. In 1999, a phase 1 study evaluating hypericin's effects in 30 patients concluded that hypericin had no antiretroviral activity, with phototoxicity being observed.(Gulick 1999...
View Full Article (HTML) More content like this Find more content: like this article ABOUT USHELPCONTACT USAGENTSADVERTISERSMEDIAPRIVACYTERMS & CONDITIONSSITE MAP Copyright © 1999–2012 John Wiley & Sons, Inc. All Rights Reserved.doi:10.1211/fact.2001.00192Wiley...